GlassScriptPhysician profile
Scott I Sircus
NPI 1295724060
$7,228.17
in general payments reported to CMS, 2019-2025
43 companies · $1,742 in 2025
The $1,742 reported for 2025 was more than what 77% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,367 · 2020: $172 · 2021: $213 · 2022: $970 · 2023: $1,524 · 2024: $1,242 · 2025: $1,742.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,169 · Travel and Lodging: $279 · Education: $59.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,168.87 |
| Travel and Lodging | $278.86 |
| Education | $59.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $892.82 | 2021-2025 | Interstim, Altaviva |
| Boston Scientific Corporation | $753.12 | 2019-2025 | Ams 700, Axonics, Lithovue |
| Teleflex LLC | $714.00 | 2022-2025 | Urolift |
| Ferring Pharmaceuticals INC. | $702.79 | 2019-2025 | Adstiladrin |
| Allergan, INC. | $395.21 | 2019-2022 | |
| Procept Biorobotics Corporation | $336.47 | 2022-2024 | Aquabeam System, Aquabeam Robotic System |
| Janssen Scientific Affairs, LLC | $227.52 | 2022-2025 | |
| Axonics, INC. | $214.64 | 2022-2024 | Axonics, Bulkamid |
| Coloplast Corp | $208.41 | 2019-2024 | Saffron |
| Antares Pharma, INC. | $207.90 | 2021-2025 | Xyosted |
| Myriad Genetic Laboratories, INC. | $206.17 | 2021-2025 | Prolaris |
| Dornier Medtech America, INC | $186.68 | 2023 | Dornier Medtech |
| Bioprotect Medical, INC. | $178.12 | 2025 | Bioprotect Balloon Implant System |
| Medtronic USA, INC. | $176.17 | 2019 | |
| Dendreon Pharmaceuticals LLC | $156.21 | 2024-2025 | Provenge |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calyxo, INC. | $152.14 | 2025 | Cvac Aspiration System |
| Urogen Pharma, INC. | $138.82 | 2023-2025 | Jelmyto |
| Laborie Medical Technologies Corp. | $133.42 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Sumitomo Pharma America, INC. | $116.02 | 2024-2025 | Orgovyx, Gemtesa |
| Astellas Pharma US INC | $101.17 | 2019-2025 | Xtandi |
| Amgen INC. | $95.44 | 2019-2022 | |
| Cook Medical LLC | $93.36 | 2025 | Cook |
| Abbvie INC. | $93.23 | 2023-2025 | Botox |
| Endo Pharmaceuticals INC. | $80.19 | 2019-2023 | Xiaflex |
| Merck Sharp & Dohme LLC | $71.93 | 2022-2023 | Keytruda, Lynparza |
| Pfizer INC. | $63.82 | 2019-2024 | |
| Tolmar, INC. | $53.35 | 2024-2025 | Jatenzo, Eligard |
| Janssen Biotech, INC. | $52.09 | 2019-2023 | Erleada |
| Olympus America INC. | $50.45 | 2025 | Itind System |
| Astrazeneca Pharmaceuticals LP | $50.00 | 2021-2025 | Imfinzi |
| Urovant Sciences INC | $40.48 | 2021-2022 | |
| Immunitybio, INC. | $39.59 | 2024-2025 | |
| 180 Medical, INC. | $34.75 | 2022-2023 | |
| Clarus Therapeutics INC. | $30.97 | 2021 | |
| Neotract INC. | $26.05 | 2019-2020 | |
| Halozyme INC | $25.43 | 2023 | |
| Integra Lifesciences Corporation | $22.21 | 2024 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Photocure INC | $21.83 | 2024 | Cysview |
| Travere Therapeutics, INC. | $20.10 | 2019 | |
| Sun Pharmaceutical Industries INC. | $19.36 | 2019 | |
| Blue Earth Diagnostics | $16.60 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.73 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $13.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Sircus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.